Results 21 to 30 of about 2,866 (241)

The clinical and radiological effectiveness of autologous bone marrow derived osteoblasts (ABMDO) in the management of avascular necrosis of femoral head (ANFH) in sickle cell disease (SCD)

Journal of Experimental Orthopaedics, Volume 9, Issue 1, 2022., 2022
Abstract Purpose Avascular necrosis of the femoral head is a common issue faced by orthopaedic surgeons that ranges between 10 and 18%, but in patients with SCD, the incidence reaches 30%. There is no definite treatment except joint arthroplasty. Regenerative medicine is an option to cure or delay joint arthroplasty.
Mir Sadat‐Ali, Abdallah S. Al‐Omran, Khalid AlTabash, Sadananda Acharya, Tarek M. Hegazi, Mona I. Al Muhaish   +5 more
wiley   +1 more source

Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease—A single center experience

Pediatric Transplantation, Volume 25, Issue 2, March 2021., 2021
Abstract HSCT is curative in SCD. Patients with HLA‐identical sibling donor have an excellent outcome ranging from 90%‐100% overall and event‐free survival. However, due to the lack of matched sibling donors this option is out of reach for 70% of patients with SCD. The pool of potential donors needs to be extended.
Friederike Kogel, Dani Hakimeh, Pietro Sodani, Peter Lang, Jörn‐Sven Kühl, Patrick Hundsdoerfer, Annette Künkele, Angelika Eggert, Lena Oevermann, Johannes H. Schulte   +9 more
wiley   +1 more source

Shoulder Osteonecrosis: Pathogenesis, Causes, Clinical Evaluation, Imaging, and Classification

Orthopaedic Surgery, Volume 12, Issue 5, Page 1340-1349, October 2020., 2020
The humeral head is the second site for osteonecrosis; it is associated with traumatism, corticosteroid use, sickle‐cell disease, alcoholism, dysbarism (or caisson disease), Gaucher's disease, and other conditions. The humeral head is the second most common site for nontraumatic osteonecrosis after the femoral head, yet it has attracted relatively ...
Philippe Hernigou, Jacques Hernigou, Marius Scarlat   +2 more
wiley   +1 more source

Osteonecrose maxilar em pacientes portadores de doenças neoplásicas sob uso de bisfosfonatos Jaw osteonecrosis in patients with neoplastic diseases taking bisphosphonates

Revista Brasileira de Hematologia e Hemoterapia, 2008
A osteonecrose induzida por bisfosfonatos é uma complicação que pode ocorrer em pacientes acometidos por doença osteolítica tais como mieloma múltiplo, portadores de metástases tumorais em tecido ósseo, osteoporose e que fizeram uso de droga do grupo dos
Paulo S. S. Santos, Liane M. Gambirazi, Valtuir B. Felix, Marina Helena C. G. Magalhães   +3 more
doaj   +1 more source

Painful hip in children [PDF]

, 2005
Universidade Federal de São Paulo (UNIFESP) Departamento de Diagnóstico por ImagemUNIFESP Setor de Reumatologia PediátricaUNIFESPUNIFESP, Depto.
Amaral, Denise Tokechi, Fernandes, Artur da Rocha Correa, Hilário, Maria Odete Esteves, Honda, Eduardo, Lederman, Henrique Manoel, Narahashi, Érica, Natour, Jamil, Zoner, Cristiane Soares   +7 more
core   +3 more sources

Effect of Periapical Diseases in Development of MRONJ in Immunocompromised Mouse Model

BioMed Research International, Volume 2019, Issue 1, 2019., 2019
Objectives. This study aimed to assess the effect of zoledronic acid on an immunocompromised mice model with periapical disease. Materials and Methods. Thirty C57BL/6N mice were randomly divided into three groups (N = 10). All animals were subjected to bilateral ovariectomy (OVX) and then treated with saline (Veh), zoledronic acid (ZA), or concomitant ...
Nian Jing Rao, Ru Qing Yu, Jing Yi Wang, Alexandra Helm, Li Wu Zheng, Atif A. Ahmed   +5 more
wiley   +1 more source

Osteonecrosis in a Patient with Crohn′s Disease Unrelated to Corticosteroid Use

Canadian Journal of Gastroenterology and Hepatology, Volume 15, Issue 11, Page 765-768, 2001., 2001
Osteonecrosis is a feared complication of corticosteroid use. However, a direct association between corticosteroid use and osteonecrosis has never been proven. The present report examines the case of a patient with longstanding Crohn′s disease who had never been treated with corticosteroids and who developed osteonecrosis of the talus.
Ali Khan, Gerald Illiffe, Donald S Houston, Charles N Bernstein   +3 more
wiley   +1 more source

Comparative study between primary and secondary antiphospholipid syndrome: clinic and laboratorial characteristics of 149 patients [PDF]

, 2008
OBJETIVOS: O presente estudo tem como objetivo analisar as características clínicas, laboratoriais e imunológicas dos pacientes com síndrome antifosfolípide (SAF) e comparar indivíduos portadores da síndrome primária com portadores da secundária ...
CARVALHO, Jozélio Freire de, GRANDO, Paulo Eduardo Daruge, QUAIO, Caio Robledo D'Angioli Costa   +2 more
core   +2 more sources

Prevalence Rates and an Evaluation of Reported Risk Factors for Osteonecrosis (Avascular Necrosis) in Crohn’s Disease

Canadian Journal of Gastroenterology and Hepatology, Volume 14, Issue 2, Page 138-143, 2000., 2000
Avascular necrosis (osteonecrosis) occurs in Crohn’s disease, but the rate of this particular complication is not known. Over 20 years, 877 patients with Crohn’s disease, 492 women (56.1%) and 385 men (43.9%), were evaluated with patient follow‐up data available for a mean of 7.8 years. In this group, four men were seen with osteonecrosis. No woman was
Hugh J Freeman, Katy J Freeman
wiley   +1 more source

Osteomyelitis and Osteonecrosis in Inflammatory Bowel Disease

Canadian Journal of Gastroenterology and Hepatology, Volume 11, Issue 7, Page 601-606, 1997., 1997
Osteomyelitis and osteonecrosis are skeletal disorders seen in patients with inflammatory bowel disease (IBD). Osteomyelitis usually occurs in the pelvic bones, especially in complicated Crohn′s disease, presumably by direct extension from a pelvic inflammatory mass, abscess or fistulous tract.
Hugh J Freeman
wiley   +1 more source